A type of non-Hodgkin's lymphoma that most often occurs in young people aged 12-30. |
Burkitt's Lymphoma Resources | |
Cancer.gov: |
COMMON CANCER ACRONYMSAcronyms seen often on mailing lists, newsgroups, web sites, and other material. ALL acute lymphocytic leukemia (+3 subtypes according to morphology. L1-L3 and subtypes according to phenotype: T, pre-B, pre-pre-B, B) BCP-ALL B-cell precursor acute lymphoblastic leukemia AML acute myelogeneous leukemia (+8 subtypes MO-M6) AMML acute myelogeneous leukemia ANLL acute non-lymphocytic leukemia (included in AML above) APL acute prolymphocytic leukemia APML acute promyelocytic leukemia CLL chronic lymphocytic leukemia CML chronic myeloid leukemia (each has subtypes) HCL hairy cell leukemia BL Burkitt's lymphoma CNSL central nervous system lymphoma HD Hodgkins lymphoma (4 subtypes) NHL non-Hodgkins lymphoma (many subtypes) MCL mantle cell lymphoma MF mycosis fungoides (cutaneous T-cell lymphoma) AA aplastic anemia MDS myelodysplastic syndrome (4 subtypes) MM multiple myeloma MPD myeloproliferative disorders PV polycythemia vera WM Waldenstrom's Macroglobulinemia ABMT autologous bmt- your own marrow BMT allogeneic bmt- someone else's marrow SBMT syngeneic bmt- identical twin's marrow MUD a transplant using a matched unrelated donor PBPC peripheral blood progenitor cell transplant (which is becoming the new standard term ) PBSCT peripheral blood stem cell transplant PBSCR peripheral blood stem cell rescue PSCT or PSCR The same as above without the word "blood." ACOB doxorubicin, cyclophosphamide, vincristine, bleomycin ABVD doxorubicin, vinblastine, bleomycin, DTIC ARA-C cytarabine ATRA all-trans retinoic acid, or Vesanoid BACOP bleomycin, doxorubicin, cyclophosphamide, vincristine, prednisone BEAM busulfan, etoposid, ara-c, melphalan BLEO bleomycin 2CdA 2-chlorodeoxyadenosine (Generic name = cladribine) C-MOPP cyclophosphamide, oncovin, procarbazine, prednisone CCNU (1-2-chloroethyl)-3-cyclohexyl-1-nitrosourea) CHOD cyclophosphamide, doxorubicin, vincristine, dexamethasone CHOP cyclophosphamide, adriamycin, vincristine, prednisone CHOP-BLEO cyclophosphamide, doxorubicin, vincristine, prednisone and bleomycin CMF cyclophosphamide, methotrexate, fluorouacil COP cyclophosphamide, vincristine, prednisone COPP CCNU, vincristine,procarbazine, prednisone CyA cyclosporin A DCF 2-deoxycoformycin (pentostatin) DTIC dacarbazine, 5-(3,3-dimethyl-1-triazino)imidazole-4- carboxamide EPOCH etopside, prednisone, vincristine, cyclophosphamide (cytoxan), adriamycin FAC fluorouacil, adriamycin, cyclophosphamide Flu fludarabine (Fludara) IFN Interferon (comes in alpha2a, alpha 2b, human leukocyte, and beta--Another one "concensus" is still in trials) IL Interleuken mBACOD methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, dexamethasone MOPP nitrogen mustard, vincristine, procarbazine, prednisone MTX or M methotrexate proMACE prednisone, methotrexate with leukovorin rescue, doxorubicin, cyclophosphamide, etoposide (VP-16) EPOIETIN erythropoietin (Epogen)-- is used to stimulate red cell growth. G-CSF granulocyte colony stimulating factor (Neupogen)- stimulates growth of white cells . GM-CSF granulocyte macrophage - colony stimulating factor (sargramostim) NEUMEGA platelet stimulating factor TPOIETIN thrombopoietin - (platelet stimluating factor) --still in clinical trials BMA bone marrow aspiration BMB bone marrow biopsy BMT bone marrow transplant (see specifics listed above) B2M beta 2 microglobulin test. Beta-2-microglobulin is a protein found on all the surface of all cells and small amounts are shed into the serum. People diagnosed with blood diseases and who have levels of beta-2-microglobulin below 3.0 seem to have a longer survival rate. CCDRT cell culture drug resistance testing Cnet Cancernet (where one gets PDQ and Cancer Lit papers) EPOIETIN erythropoietin (Epogen)-- is used to stimulate red cell growth. EORTC European Organization for Research and Treatment of Cancer FISH Fluorescence In Situ Hybridization. It is a test used to detect chromosone abnormalities in cells and has been used to test lymphocytes in CLL. The results help to predict the prognosis for a particular patient. G-CSF granulocyte - colony stimulating factor (Neupogen)- stimulates growth of white cells GM-CSF granulocyte macrophage - colony stimulating factor (sargramostim) GVHD graft vs host disease GVL graft vs leukemia or graft vs lymphoma HDC high dose chemotherapy--often used to condition one before a BMT or PBSCT Ig Immunoglobulin (IgA, IgD, IgE, IgG, IgM) IV intravenous--into a vein Mab or MoAb monoclonal antibodies (i.e. Campath-1H, Rituxan, Bexxar) MUD matched unrelated donor of bone marrow NMDP National Marrow Donor Program --1-800-526-7809 Neumega a platelet growth factor NR nodular remission (nodules of cancer cells remain in the marrow, but there are less than 10% cancer cells throughout) OR overall remission PBSCR peripheral blood stem cell rescue --same as PBSCT below PBSCT peripheral blood stem cell transplant PDQ physicians data query PR partial remission SWOG Southwest Oncology Group TPOIETIN thrombopoietin - (platelet stimluating factor) Bx Biopsy B/P Blood Pressure CR complete remission CRN complete remission with nodular pattern in marrow CS Clinical Stage CBC Complete Blood Count Dx Diagnosis GP General Practitioner: Doctor within NHS (UK) HCT Hematocrit The percentage of red blood cells in the blood. A low hematocrit measurement indicates anemia. Hem/Onc hematologist/oncologist HGB hemoglobin HLA Human leukocyte antigen test A special blood test used to match a blood or bone marrow donor to a recipient for transfusion or transplant. IV intravenous, placed directly into a vein MD Medical Doctor (USA) OR overall remission PR partial remission RBC red blood count RX prescribed medication TBI total body irradiation WBC white blood count WBC/HPF white blood cells counted per high powered field WD well differentiated WW watch and wait (also called, watch and worry) XRT external radiation therapy CIS cancer information service (of NCI) 1-800-4-CANCER FDA Food and Drug Administration (USA) NCI National Cancer Institute (USA) NIH National Institutes of Health (USA) LRF Leukaemia Research Fund (UK) LSA Leukemia Society of America (USA) NHS National Health Service (UK) This page last modified Sunday, 16-Mar-2003 02:33:04 CST |
| |
Copyright © 1999-2010 Kenneth S. Martin All Rights Reserved Worldwide |